orfiril long 150 mg toimeainet prolongeeritult vabastav kõvakapsel
desitin arzneimittel gmbh - valproehape - toimeainet prolongeeritult vabastav kõvakapsel - 150mg 100tk
orfiril long 300 mg toimeainet prolongeeritult vabastav kõvakapsel
desitin arzneimittel gmbh - valproehape - toimeainet prolongeeritult vabastav kõvakapsel - 300mg 100tk
orfiril 600 gastroresistentne tablett
desitin arzneimittel gmbh - valproehape - gastroresistentne tablett - 600mg 50tk
thrombo ass gastroresistentne tablett
g.l. pharma gmbh - atsetüülsalitsüülhape - gastroresistentne tablett - 75mg 30tk
hjertemagnyl õhukese polümeerikattega tablett
orifarm healthcare a/s - atsetüülsalitsüülhape+magneesiumoksiid - õhukese polümeerikattega tablett - 150mg+21mg 100tk
trexan tablett
ideal trade links uab - metotreksaat - tablett - 2,5mg 100tk
dettol med nahasprei, lahus
reckitt benckiser (poland) s.a. - bensalkooniumkloriid - nahasprei, lahus - 0,2% w/w 10ml 1tk; 0,2% w/w 100ml 1tk
nuvaxovid
novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
vidprevtyn beta
sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - vaktsiinid - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 ja 5. 1 in product information document). kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vaktsiinid - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.